Vanguard Group Inc Keros Therapeutics, Inc. Transaction History

Vanguard Group Inc

  • $6.44 Trillion
  • Q3 2025

A detailed history of Vanguard Group Inc transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 2,718,777 shares of KROS stock, worth $46.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,718,777
Previous 2,631,648 3.31%
Holding current value
$46.9 Million
Previous $35.1 Million 22.43%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025
BUY
$13.34 - $16.05 $1.16 Million - $1.4 Million
87,129 Added 3.31%
2,718,777 $43 Million
Q2 2025

Aug 11, 2025
BUY
$9.55 - $15.11 $623,872 - $987,090
65,327 Added 2.55%
2,631,648 $35.1 Million
Q1 2025

May 09, 2025
BUY
$10.15 - $16.1 $6.18 Million - $9.81 Million
609,212 Added 31.13%
2,566,321 $26.2 Million
Q4 2024

Feb 11, 2025
BUY
$15.64 - $70.0 $1.57 Million - $7.05 Million
100,691 Added 5.42%
1,957,109 $31 Million
Q3 2024

Nov 13, 2024
BUY
$41.68 - $58.07 $4.14 Million - $5.77 Million
99,298 Added 5.65%
1,856,418 $108 Million
Q2 2024

Aug 13, 2024
BUY
$44.58 - $66.89 $9.42 Million - $14.1 Million
211,362 Added 13.67%
1,757,120 $80.3 Million
Q1 2024

May 10, 2024
BUY
$41.26 - $70.48 $4.69 Million - $8 Million
113,563 Added 7.93%
1,545,758 $102 Million
Q4 2023

Feb 14, 2024
BUY
$27.12 - $41.05 $698,719 - $1.06 Million
25,764 Added 1.83%
1,432,195 $56.9 Million
Q3 2023

Nov 14, 2023
BUY
$31.57 - $43.02 $7.03 Million - $9.58 Million
222,652 Added 18.81%
1,406,431 $44.8 Million
Q2 2023

Aug 14, 2023
BUY
$37.26 - $51.01 $5.06 Million - $6.92 Million
135,717 Added 12.95%
1,183,779 $47.6 Million
Q1 2023

May 15, 2023
BUY
$41.44 - $59.32 $113,628 - $162,655
2,742 Added 0.26%
1,048,062 $44.8 Million
Q4 2022

Feb 10, 2023
BUY
$39.45 - $51.77 $5.47 Million - $7.18 Million
138,746 Added 15.3%
1,045,320 $50.2 Million
Q3 2022

Nov 14, 2022
BUY
$27.8 - $40.12 $3.75 Million - $5.41 Million
134,956 Added 17.49%
906,574 $34.1 Million
Q2 2022

Aug 12, 2022
BUY
$26.03 - $67.04 $911,700 - $2.35 Million
35,025 Added 4.76%
771,618 $21.3 Million
Q1 2022

May 13, 2022
BUY
$42.12 - $59.36 $121,010 - $170,541
2,873 Added 0.39%
736,593 $40.1 Million
Q4 2021

Feb 14, 2022
BUY
$36.95 - $62.89 $885,285 - $1.51 Million
23,959 Added 3.38%
733,720 $42.9 Million
Q3 2021

Nov 12, 2021
BUY
$29.27 - $43.71 $1.22 Million - $1.82 Million
41,558 Added 6.22%
709,761 $28.1 Million
Q2 2021

Aug 13, 2021
BUY
$42.4 - $70.11 $28.3 Million - $46.8 Million
668,203 New
668,203 $28.4 Million

Others Institutions Holding KROS

# of Institutions
170
Shares Held
35.5M
Call Options Held
574K
Put Options Held
325K
View Full List

About Keros Therapeutics, Inc.

KROS Quotes by TradingView
  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $445M
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email